Clinical Trial Update: Leukotriene Polymorphisms and Montelukast Response - Ancillary to LoDo Trial

View source ↗

Summary

An ancillary pharmacogenetic study within the LoDo trial investigates how leukotriene polymorphisms influence montelukast response in asthma. The study has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Montelukast (Montelukast)

Snippet

Sponsor: Nemours Children's Clinic | Conditions: Asthma, Lung Diseases | Status: COMPLETED